FDA Recall Terminated

SmartSet Endurance GMV, Gentamicin, REF 3105-040, Medium Viscosity Antibiotic Bone Cement, Sterile. SmartSet GMV Endurance Gentamicin, bone cements are self-curing, radiopaque, polymethyl methacrylate based cements, containing antibiotic, used for securing a metal or polymeric prosthesis to living bone in arthroplasty procedures where infection by gentamicin-sensitive organisms is a potential risk.

Recall: Z-0064-2014 · Initiated September 16, 2013

Recall

Recall Number
Z-0064-2014
Event Number
66248
Firm
DePuy Orthopaedics, Inc.
FEI Number
1818910
Product Code
MBB
Status
Terminated
Root Cause
No Marketing Application
Initiated
September 16, 2013
Posted
October 23, 2013
Terminated
February 24, 2015
Address
700 Orthopaedic Dr, Warsaw, IN, 46582-3994

Description

SmartSet Endurance GMV, Gentamicin, REF 3105-040, Medium Viscosity Antibiotic Bone Cement, Sterile. SmartSet GMV Endurance Gentamicin, bone cements are self-curing, radiopaque, polymethyl methacrylate based cements, containing antibiotic, used for securing a metal or polymeric prosthesis to living bone in arthroplasty procedures where infection by gentamicin-sensitive organisms is a potential risk.

Reason

The SmartSet GMV Endurance Gentamicin Bone Cement, product ref: number 3105-040 is intended for use in indications that have not been cleared by the US FDA. The intended use stated in the IFU for the SmartSet GMV Endurance Gentamicin Bone Cement is for the fixation of prostheses to living bone in arthroplasty procedures of joints in which infection by gentamicin-sensitive organisms is a potentia

Action

The firm DePuy Synthes, sent an "URGENT INFORMATION-MEDICAL DEVICE RECALL NOTICE" dated September 16, 2013 to its consignees via E-mail, hand delivery or fax depending on the most appropriate delivery method for each consignees. The Urgent recall notice described the recalled product, explained the reason for the recall, and directed consignees to cease further distribution, complete the attached Reconciliation form and quarantine and return all affected products through the DePuy Orthopaedics Sales consultant, Fax 1-787-287-7681 or Email to [email protected]. Consignees were directed to maintain a copy of the notice and forward the notice if product was further distributed. Clinical questions should be addressed to DePuy Orthopaedics, Inc's Scientific Information Office at 1-888-554-2482 (M-F; 8 a.m. - 5 p.m. EDT). Recall questions or concerns should be addressed to the Quality & Compliance Supervisor, at 1-787- 272-1900 x3114 or [email protected] (MF; 8 am- 5 pm EST).

Distribution

Distributed in Puerto Rico and US Virgin Islands.

Quantity

16,040 units